Types of Cancer Detected by PET Scan

Often, in the diagnosis and management of cancer, there is a need for detailed imaging so that one can understand where abnormal cells are located and whether a disease has spread to other parts of the body. A cancer PET Scan can provide valuable information about areas with high metabolic activity. Molecular Diagnostics and Therapy offers advanced diagnostic imaging to support cancer assessment and treatment planning.

PET is usually done with a CT scan to generate a detailed image of both metabolic activity and the body's internal structures. A PET CT scan for cancer is a combined exam and can be helpful with the diagnosis, staging, and treatment of some cancers.

What Is a PET Scan for Cancer?

A Positron Emission Tomography (PET) scan is an imaging test that allows areas of increased metabolic activity in the body to be visualized. In cancer cells, glucose is frequently used more than in normal cells, which means that a radioactive tracer can sometimes accumulate more strongly in areas in which cancer cells are present.

The scan generates images that may allow health care professionals to see suspicious areas and determine if there's any sign of cancer spreading to other parts of the body. A radioactive tracer, such as fluorodeoxyglucose (FDG), is typically used in PET scanning. The type of cancer and the purpose of the examination help determine which radiotracer is appropriate.

How Does a PET CT Scan Help in Cancer Diagnosis?

PET-CT is a combined PET and CT examination. PET allows information about metabolic activity, while CT allows detailed information on anatomy. This helps healthcare providers to gain greater insight into the nature and location of suspicious areas using both types of imaging. This may be helpful for treatment planning and monitoring response.

Types of Cancer Detected by PET Scan

PET imaging may help evaluate a variety of cancers. It is useful, though, depending on the type, size, location, and biological behaviour of the tumour.

Lung Cancer

PET CT is commonly used in the evaluation of lung cancer. It can help identify metabolically active lung lesions and assess nearby lymph nodes or possible spread to distant organs.

Lymphoma

PET CT plays an important role in evaluating many types of lymphoma. It can help identify areas affected by lymphoma and is also commonly used to assess how the disease responds to treatment.

Colorectal Cancer

PET imaging may be used in selected cases of colorectal cancer, particularly when doctors need additional information about suspected recurrence or spread to other parts of the body.

Head and Neck Cancer

PET CT can help evaluate certain head and neck cancers and may provide information about lymph node involvement or distant disease.

Esophageal Cancer

PET CT may be used as part of the staging process for certain esophageal cancers. It can help identify areas of active disease and possible spread.

Breast Cancer

PET CT is not usually the first imaging test used for detecting breast cancer. However, it may be considered in selected situations, particularly when evaluating advanced or recurrent disease.

Melanoma

PET CT can help evaluate advanced melanoma by identifying areas of increased metabolic activity that may represent cancer spread.

Cervical Cancer

PET CT may be used in selected cervical cancer cases to assess lymph nodes and look for possible distant spread, particularly when advanced disease is suspected.

Ovarian Cancer

PET imaging may sometimes be used to evaluate suspected recurrent ovarian cancer or assess areas that are difficult to characterize with other imaging methods.

Can PET CT Detect Cancer Early?

PET CT identifies regions where there is greater metabolic activity and does not detect cancer in everyone. PET-CT may have limited sensitivity for some small tumours and cancers with low metabolic activity. Therefore, PET CT is most often performed when there is a particular clinical indication for the test, but it is not considered to be a general screening procedure for the detection of all cancers.

PET CT Scan Accuracy

When looking for PET scan accuracy, people may think that there is one percentage that stands out, but there isn't one for each cancer. This varies depending on the type, stage of cancer, the tracer, the type of imaging equipment, and other clinical factors.

The results obtained from a PET CT also must be interpreted according to the medical history, physical examination, laboratory determination, and the results of other imaging procedures. The uptake of the tracer doesn't necessarily indicate cancer. The increased uptake may be due to infection or inflammation. Likewise, there are some cancers that exhibit relatively low uptake.

How PET CT Helps During Cancer Treatment

PET CT can be helpful throughout the cancer treatment process. It can help health practitioners to identify the extent of the disease and plan the treatment, to monitor the treatment effect, and to assess a suspected recurrence. Provided it is performed at the right time, PET CT can offer data that may be added to that of other imaging procedures.

PET CT Scan at Molecular Diagnostics and Therapy

The PSMA PET-CT scan is used to diagnose and monitor prostate cancer. PET CT scan is a diagnostic and monitoring tool used for prostate cancer. The selection of the right diagnostic centre in the imaging process is crucial. PET CT imaging is available for the evaluation, staging, monitoring, and follow-up of cancer. Instructions for patients are given before the scan, and any medical conditions or medications that may have bearing on the scan should be discussed with the healthcare team.

Conclusion

PET can identify areas of increased or decreased tracer uptake and provide information about tissue metabolism, and can help assess several types of cancer, such as lung, lymphoma, colorectal, head, neck, melanoma, and some breast, cervical, ovarian, and esophageal cancers. Where appropriate, a PET CT scan for cancer can combine metabolic and anatomical imaging and can be helpful for the staging, treatment planning, and monitoring of cancer. 

The diagnostic performance of PET/CT varies according to the cancer type, tracer, tumour characteristics, and clinical setting. At Molecular Diagnostics and Therapy, patients can count on support throughout various phases of cancer evaluation and monitoring using advanced diagnostic imaging and PET CT scans.